Company intelligence / Profile preview

Core Pharmaceuticals

Anyang-si, Gyeonggi-do, South Korea

Ownership: Private
Development stage: Other

Overview

Core Pharmaceuticals is a South Korean biotechnology company specializing in the development of advanced drug delivery systems (DDS). The company's proprietary Core-DDS platform focuses on creating long-acting injectable (LAI) formulations of existing small molecule drugs to improve patient compliance and therapeutic efficacy. Their lead pipeline candidates include sustained-release treatments for Alzheimer's disease and Schizophrenia. Beyond CNS disorders, Core Pharmaceuticals is expanding its technology into metabolic diseases and hair loss treatments. The company aims to provide value-added medicines by optimizing the pharmacokinetic profiles of proven therapeutic agents.

Therapeutic areas: PsychiatryEndocrinologyNeurologyDermatology
Modalities: Small moleculePeptides
Industry: Biotech

Beyond the preview

Go deeper on Core Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Core Pharmaceuticals.

Explore the full profile